Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.17M | $157.0M | 5.73% | +2.60M | 2026-03-31 |
| Deep Track Capital, LP | 6.77M | $149.0M | 5.42% | -- | 2026-03-31 |
| SAMSARA BIOCAPITAL, LLC | 6.35M | $139.0M | 5.07% | +588.2K | 2026-03-31 |
| Foresite Capital Management V, LLC | 5.90M | $129.0M | 4.72% | +117.6K | 2026-03-31 |
| Foresite Capital Management VI LLC | 4.25M | $93.0M | 3.40% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.03M | $88.0M | 3.22% | -- | 2026-03-31 |
| Cormorant Asset Management, LP | 3.95M | $87.0M | 3.16% | +313.6K | 2026-03-31 |
| Nextech Invest, Ltd. | 3.54M | $78.0M | 2.83% | +625.0K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.29M | $72.0M | 2.63% | +3.24M | 2026-03-31 |
| Saturn V Capital Management LP | 3.20M | $70.0M | 2.56% | +66.1K | 2026-03-31 |
